Skip to main content
BLND
NYSE Technology

Blend Labs Exceeds Q4/FY25 Guidance, Authorizes Substantial $50M Share Repurchase Program

Analysis by Wiseek.ai
Sentiment info
Positive
Importance info
9
Price
$1.68
Mkt Cap
$423.387M
52W Low
$1.57
52W High
$4.49
Market data snapshot near publication time

summarizeSummary

Blend Labs reported preliminary Q4 and full-year 2025 results exceeding non-GAAP operating income guidance and achieving full-year non-GAAP profitability, alongside authorizing a new $50 million share repurchase program.


check_boxKey Events

  • Exceeds Q4 and Full Year 2025 Guidance

    The company reported preliminary Q4 2025 revenue of $32.4 million (up 7% YoY), near the high end of guidance, and non-GAAP operating income of $5.4 million, exceeding the high end of guidance. For the full year 2025, revenue was $123.5 million (up 7% YoY).

  • Achieves Full Year Non-GAAP Operating Income Profitability

    Blend Labs achieved non-GAAP operating income of $15.1 million for the full fiscal year 2025, a significant improvement from a loss of $12.8 million in 2024, indicating a positive shift in operational performance.

  • Authorizes Substantial $50 Million Share Repurchase Program

    The Board of Directors authorized a new share repurchase program for up to $50.0 million of Class A common stock. This authorization is significant, representing approximately 11.8% of the company's current market capitalization, and follows $25 million in repurchases already completed in 2025.

  • Introduces Q1 2026 Guidance

    The company provided Q1 2026 guidance, expecting total revenue between $28.5 million and $30.0 million, and non-GAAP operating income between $2.0 million and $3.0 million.


auto_awesomeAnalysis

Blend Labs, Inc. announced strong preliminary financial results for Q4 and the full fiscal year 2025, surpassing its non-GAAP operating income guidance and achieving positive non-GAAP operating income for the full year. This turnaround in profitability, coupled with revenue near the high end of guidance, signals improved operational efficiency and financial health. Concurrently, the board authorized a new share repurchase program of up to $50 million, which is a significant commitment relative to the company's market capitalization and demonstrates management's confidence in the company's valuation and future cash flow generation. This follows $25 million in repurchases already made in 2025. The combination of strong financial performance and a substantial capital return program is a highly positive market signal.

At the time of this filing, BLND was trading at $1.68 on NYSE in the Technology sector, with a market capitalization of approximately $423.4M. The 52-week trading range was $1.57 to $4.49. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BLND - Latest Insights

BLND
Mar 16, 2026, 6:05 AM EDT
Source: Wiseek News
Importance Score:
8
BLND
Mar 13, 2026, 5:40 PM EDT
Filing Type: 10-K
Importance Score:
8
BLND
Mar 10, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
BLND
Mar 10, 2026, 4:00 PM EDT
Source: Dow Jones Newswires
Importance Score:
9
BLND
Mar 02, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
BLND
Jan 06, 2026, 4:18 PM EST
Filing Type: 8-K
Importance Score:
7